ProfileGDS4718 / 217998_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 68% 71% 69% 71% 71% 72% 70% 69% 68% 72% 69% 68% 68% 69% 73% 73% 68% 71% 76% 76% 69% 69% 64% 68% 71% 68% 71% 66% 66% 78% 73% 77% 74% 70% 70% 68% 73% 71% 73% 66% 72% 67% 81% 69% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.697868
GSM549102patient 115, normal, homogenized [OPG study]6.9471671
GSM549104patient 119, normal, homogenized [OPG study]6.8161669
GSM549108patient 138, normal, homogenized [OPG study]6.9234271
GSM549119patient 077, normal, homogenized [OPG study]6.9028571
GSM549133patient 032, cancer, homogenized [OPG study]7.1573372
GSM549139patient 042, cancer, homogenized [OPG study]6.9166170
GSM549099patient 107, normal, homogenized [OPG study]6.7447969
GSM549109patient 139, normal, homogenized [OPG study]6.7076468
GSM549110patient 046, normal, homogenized [OPG study]6.9784272
GSM549114patient 063, normal, homogenized [OPG study]6.7673169
GSM549122patient 082, normal, homogenized [OPG study]6.7618768
GSM549134patient 033, cancer, homogenized [OPG study]6.7357968
GSM549136patient 036, cancer, homogenized [OPG study]6.8381469
GSM549140patient 044, cancer, homogenized [OPG study]7.2480973
GSM549111patient 047, normal, homogenized [OPG study]7.1422273
GSM549113patient 057, normal, homogenized [OPG study]6.7034168
GSM549132patient 031, cancer, homogenized [OPG study]6.9920671
GSM549137patient 038, cancer, homogenized [OPG study]7.4501676
GSM549142patient 047, cancer, homogenized [OPG study]7.3246376
GSM549100patient 110, normal, homogenized [OPG study]6.7228369
GSM549107patient 135, normal, homogenized [OPG study]6.782269
GSM549115patient 068, normal, homogenized [OPG study]6.3765464
GSM549116patient 072, normal, homogenized [OPG study]6.7162768
GSM549120patient 078, normal, homogenized [OPG study]6.9599671
GSM549131patient 030, cancer, homogenized [OPG study]6.7513668
GSM549118patient 074, normal, homogenized [OPG study]6.9402671
GSM549129patient 027, cancer, homogenized [OPG study]6.59966
GSM549123patient 088, normal, homogenized [OPG study]6.5298366
GSM549124patient 006, cancer, homogenized [OPG study]7.5526278
GSM549126patient 015, cancer, homogenized [OPG study]7.1876673
GSM549128patient 025, cancer, homogenized [OPG study]7.6364377
GSM549103patient 117, normal, homogenized [OPG study]7.1734774
GSM549117patient 073, normal, homogenized [OPG study]6.7890970
GSM549138patient 041, cancer, homogenized [OPG study]6.8926270
GSM549141patient 045, cancer, homogenized [OPG study]6.8063268
GSM549130patient 028, cancer, homogenized [OPG study]7.0927873
GSM549101patient 111, normal, homogenized [OPG study]6.9569471
GSM549105patient 128, normal, homogenized [OPG study]7.0779573
GSM549106patient 134, normal, homogenized [OPG study]6.6246766
GSM549112patient 048, normal, homogenized [OPG study]7.0011372
GSM549125patient 011, cancer, homogenized [OPG study]6.6207467
GSM549127patient 024, cancer, homogenized [OPG study]8.0487981
GSM549135patient 035, cancer, homogenized [OPG study]6.8235669